Display options
Share it on

Vaccines (Basel). 2021 Sep 23;9(10). doi: 10.3390/vaccines9101057.

Impacts of Quarterly Sow Mass Vaccination with a Porcine Reproductive and Respiratory Syndrome Virus Type 1 (PRRSV-1) Modified Live Vaccine in Two Herds.

Vaccines

Kasper Pedersen, Charlotte Sonne Kristensen, Lise Kirstine Kvisgaard, Lars Erik Larsen

Affiliations

  1. SEGES Danish Pig Research Centre, Agro Food Park 15V, 8200 Aarhus N, Denmark.
  2. Faculty of Health and Medical Sciences, Department of Veterinary and Animal Sciences, University of Copenhagen, 1870 Frederiksberg C, Denmark.

PMID: 34696165 PMCID: PMC8537578 DOI: 10.3390/vaccines9101057

Abstract

In recent years, there has been a considerable increase in the use of Modified Live PRRSV Vaccines (MLV) for mass vaccination in Denmark. The potential risks and negative impact of this strategy have been sparsely studied. The aim of this study was to investigate the impact of quarterly sow mass vaccination in two Danish sow herds. The study was performed as an observational prospective cohort of 120 sows in each of two commercial breeding herds in a paired design. Blood samples were taken from sows and oral fluid samples from nursery pigs (four to ten weeks old) before and after vaccination. The presence of PRRSV-1 RNA was measured by real time quantitative reverse transcription-polymerase chain reaction (RT-qPCR), and the level of PRRSV-1 specific antibodies was measured by two different serological assays. PRRS virus was not detected in the sow herds two days before and two weeks after vaccination, but the vaccine strain virus was detected in the nursery pigs. The prevalence of sows without antibodies towards PRRSV-1 went from 6-15% before vaccination to 1-4% after vaccination depending on the serological assay used, despite the fact that they had previously been repeatedly vaccinated. Four sows tested negative for antibodies in both assays after vaccination.

Keywords: PRRSV; immune response; mass vaccination; serological assay

References

  1. Vet Microbiol. 2007 Jul 20;123(1-3):69-85 - PubMed
  2. Porcine Health Manag. 2019 Dec 15;5:26 - PubMed
  3. Can J Vet Res. 2009 Oct;73(4):303-7 - PubMed
  4. J Virol. 2002 May;76(9):4241-50 - PubMed
  5. Vet Rec. 2006 Apr 8;158(14):475-8 - PubMed
  6. Vet Rec. 2020 Feb 1;186(4):123 - PubMed
  7. Virus Res. 2013 Dec 26;178(2):197-205 - PubMed
  8. Vaccines (Basel). 2021 Apr 22;9(5): - PubMed
  9. Clin Infect Dis. 2016 Jul 1;63(1):21-32 - PubMed
  10. Sci Rep. 2020 Feb 3;10(1):1649 - PubMed
  11. Am J Vet Res. 2001 Dec;62(12):1876-80 - PubMed
  12. Am J Vet Res. 2014 Mar;75(3):260-7 - PubMed
  13. Nat Commun. 2019 Jul 26;10(1):3338 - PubMed
  14. Virus Res. 2010 Dec;154(1-2):114-22 - PubMed
  15. PLoS One. 2015 Dec 16;10(12):e0144265 - PubMed
  16. Vet Microbiol. 2005 Dec 20;111(3-4):151-7 - PubMed
  17. Tierarztl Prax Ausg G Grosstiere Nutztiere. 2011;39(2):101-12 - PubMed
  18. Hum Vaccin Immunother. 2016;12(1):239-43 - PubMed
  19. Transbound Emerg Dis. 2020 Mar 27;: - PubMed
  20. J Vet Diagn Invest. 2012 Sep;24(5):855-66 - PubMed
  21. Porcine Health Manag. 2020 Oct 6;6:26 - PubMed
  22. Porcine Health Manag. 2021 Jan 4;7(1):6 - PubMed
  23. Vet J. 2013 Aug;197(2):438-44 - PubMed
  24. Vet Microbiol. 2014 Jan 31;168(2-4):331-9 - PubMed
  25. Viral Immunol. 2004;17(1):25-37 - PubMed
  26. Vaccine. 2018 Feb 8;36(7):949-957 - PubMed
  27. Vet Microbiol. 2013 Dec 27;167(3-4):334-44 - PubMed
  28. Clin Vaccine Immunol. 2015 Jun;22(6):631-40 - PubMed
  29. Porcine Health Manag. 2019 Feb 19;5:8 - PubMed
  30. Vet Microbiol. 2019 Oct;237:108406 - PubMed

Publication Types

Grant support